GeNO Healthcare (GNO) Withdrawn

Developing inhaled nitric oxide products to treat pulmonary and cardiac diseases.

Health Care -

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
GeNO Healthcare IPO News more
  • .
IPO Data
IPO File Date 11/12/2013
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $50
 
IPO Data
IPO Date
Offer Price
Price Range n/a
Offer Shares (mm) n/a
Deal Size ($mm) $$50
 
Underwriters
more
Business Overview
Developing inhaled nitric oxide products to treat pulmonary and cardiac diseases.
Developing inhaled nitric oxide products to treat pulmonary and cardiac diseases.
more
Company Data
Headquarters Waltham, MA
Founded 2006
Employees 30
Website www.genocorp.com
 

Performance vs. IPO Index (IPOUSA)